Brown Advisory’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-1,419,586
Closed -$271K 1031
2015
Q3
$271K Buy
1,419,586
+3,586
+0.3% +$1.22K ﹤0.01% 821
2015
Q2
$991K Sell
1,416,000
-3,536
-0.2% -$2.45K ﹤0.01% 526
2015
Q1
$963K Hold
1,419,536
﹤0.01% 558
2014
Q4
$1.12M Sell
1,419,536
-2,733
-0.2% -$1.87K ﹤0.01% 535
2014
Q3
$661K Sell
1,422,269
-575
-0% -$279 ﹤0.01% 621
2014
Q2
$712K Hold
1,422,844
﹤0.01% 612
2014
Q1
$441K Buy
1,422,844
+1,300,000
+1,058% +$483K ﹤0.01% 700
2013
Q4
$42K Buy
122,844
+71,000
+137% +$85.8K ﹤0.01% 904
2013
Q3
$105K Hold
51,844
﹤0.01% 818
2013
Q2
$98K Buy
+51,844
New +$91.1K ﹤0.01% 798

Other funds holding GCVRZ

Brown Advisory's GCVRZ Position: Q4 2015 in Review

Brown Advisory sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2015, closing a stake of 1,419,586 shares — an estimated $271K sold.

Brown Advisory first reported a position in GCVRZ in Q2 2013 and held it in 10 quarters. The position peaked at $1.12M in Q4 2014. 114 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2015.

  • Brown Advisory reported no remaining Sanofi Contingent Value Rights position as of Q4 2015 after selling out during the quarter.
  • Brown Advisory sold 1,419,586 Sanofi Contingent Value Rights shares in Q4 2015, an estimated $271K.
  • Brown Advisory first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 10 quarters.
  • Brown Advisory's Sanofi Contingent Value Rights position peaked at $1.12M in Q4 2014.
  • 114 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2015.

Based on Brown Advisory's 13F filing for Q4 2015, filed 8 Feb 2016.